PROCEPT BioRobotics Corp (PRCT) stock
PRCTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/3051% below fair value
$23.51+0.17 (+0.73%)
Close on Nov 12, 2026Market cap $1.35BP/E –Yield –
PROCEPT BioRobotics operating margin
Operating margin is operating income as a percentage of revenue.
PROCEPT BioRobotics's operating margin for the twelve months ending Sep 30, 2026 was -33.6%. For fiscal 2025 it was -33.7%, against -43.0% the year before. The highest annual figure on record is -33.7% in fiscal 2025.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -33.7% | +9.3 |
| FY2024 | Dec 31, 2024 | -43.0% | +37.1 |
| FY2023 | Dec 31, 2023 | -80.2% | +27.5 |
| FY2022 | Dec 31, 2022 | -107.6% | +49.5 |
| FY2021 | Dec 31, 2021 | -157.1% | +462.3 |
| FY2020 | Dec 31, 2020 | -619.4% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -27.9% | −0.0 |
| Q2 FY2026 | Jun 30, 2026 | -29.0% | −1.0 |
| Q1 FY2026 | Mar 31, 2026 | -39.2% | +0.5 |
| Q4 FY2025 | Dec 31, 2025 | -40.6% | −11.8 |
| Q3 FY2025 | Sep 30, 2025 | -27.8% | +10.6 |
| Q2 FY2025 | Jun 30, 2025 | -28.0% | +22.3 |
| Q1 FY2025 | Mar 31, 2025 | -39.7% | +22.4 |
| Q4 FY2024 | Dec 31, 2024 | -28.9% | +38.9 |
| Q3 FY2024 | Sep 30, 2024 | -38.4% | +34.5 |
| Q2 FY2024 | Jun 30, 2024 | -50.3% | +27.1 |
| Q1 FY2024 | Mar 31, 2024 | -62.1% | +54.2 |
| Q4 FY2023 | Dec 31, 2023 | -67.8% | +37.5 |
| Q3 FY2023 | Sep 30, 2023 | -73.0% | +35.7 |
| Q2 FY2023 | Jun 30, 2023 | -77.4% | +29.7 |
| Q1 FY2023 | Mar 31, 2023 | -116.3% | −5.7 |
| Q4 FY2022 | Dec 31, 2022 | -105.3% | +60.7 |
| Q3 FY2022 | Sep 30, 2022 | -108.6% | +39.0 |
| Q2 FY2022 | Jun 30, 2022 | -107.1% | +48.5 |
| Q1 FY2022 | Mar 31, 2022 | -110.6% | +47.1 |
| Q4 FY2021 | Dec 31, 2021 | -166.0% | +244.0 |
| Q3 FY2021 | Sep 30, 2021 | -147.6% | +373.4 |
| Q2 FY2021 | Jun 30, 2021 | -155.6% | – |
| Q1 FY2021 | Mar 31, 2021 | -157.7% | – |
| Q4 FY2020 | Dec 31, 2020 | -410.0% | – |
| Q3 FY2020 | Sep 30, 2020 | -521.0% | – |
See a number that looks wrong?